PPI Pharmaceuticals LLC

Irmo, SC

UEI
DJJUZJ94N9B4
CAGE
70VQ2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
800 Rocky Creek Way, Irmo, SC 29063, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

PPI Pharmaceuticals LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Investigating abbapolin PLK1 polo box domain inhibitors as potential therapeutics for colorectal cancers - polo-like… Grant · R41CA298584 National Cancer Institute $395,724
Polo-box PLK1 inhibitors target tumors resistant to ATP competitive compounds Grant · R41CA213711 National Cancer Institute $224,933
Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics Grant · R41CA189620 National Institutes of Health $224,898

Quick answers

What is PPI Pharmaceuticals LLC's UEI?

PPI Pharmaceuticals LLC's Unique Entity ID (UEI) in SAM.gov is DJJUZJ94N9B4.

What is PPI Pharmaceuticals LLC's CAGE code?

PPI Pharmaceuticals LLC's CAGE code is 70VQ2.

What is PPI Pharmaceuticals LLC's primary NAICS code?

PPI Pharmaceuticals LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is PPI Pharmaceuticals LLC located?

PPI Pharmaceuticals LLC's physical address in SAM.gov is 800 Rocky Creek Way, Irmo, SC 29063, USA.

Is PPI Pharmaceuticals LLC registered in SAM.gov?

Yes. PPI Pharmaceuticals LLC's SAM.gov registration is active through May 1, 2027.

What is PPI Pharmaceuticals LLC's most recent federal award?

PPI Pharmaceuticals LLC's most recent federal grant award is Investigating abbapolin PLK1 polo box domain inhibitors as potential therapeutics for colorectal cancers - polo-like… (R41CA298584), from National Cancer Institute, on August 1, 2025.

On GovTribe

See PPI Pharmaceuticals LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login